Abstract: The present invention relates to a delivery system suitable for delivering a substance into a XCR1 positive professional antigen-presenting cell, one or more nucleic acids coding for the same, a vector comprising the nucleic acid(s), a medicament comprising the delivery system or the one or more nucleic acid(s) and an adjuvant comprising XCL1 or a functionally active fragment thereof.
Type:
Grant
Filed:
November 19, 2008
Date of Patent:
July 7, 2020
Assignee:
BUNDESREPUBLIK DEUTSCHLAND LETZVERTRETEN DURCH DAS ROBERT KOCH-INSTITUT VERTRETEN DURCH SEINEN PRAESIDENTEN